Groen HJ - Search Results

1

Management of crizotinib therapy for ALK-rearranged non-small cell lung carcinoma: an expert consensus.

Cappuzzo F, Moro-Sibilot D, Gautschi O, Boleti E, Felip E, Groen HJ, Germonpré P, Meldgaard P, Arriola E, Steele N, Fox J, Schnell P, Engelsberg A, Wolf J. Cappuzzo F, et al. Among authors: groen hj. Lung Cancer. 2015 Feb;87(2):89-95. doi: 10.1016/j.lungcan.2014.12.010. Epub 2014 Dec 18. Lung Cancer. 2015. PMID: 25576294 Free article. Review.

2

Continuous carboplatin infusion during 6 weeks' radiotherapy in locally inoperable non-small-cell lung cancer: a phase I and pharmacokinetic study.

Groen HJ, van der Leest AH, de Vries EG, Uges DR, Szabó BG, Mulder NH. Groen HJ, et al. Br J Cancer. 1995 Oct;72(4):992-7. doi: 10.1038/bjc.1995.448. Br J Cancer. 1995. PMID: 7547255 Free PMC article. Clinical Trial.

3

Surgical resection for small cell carcinoma of the lung: a retrospective study.

Smit EF, Groen HJ, Timens W, de Boer WJ, Postmus PE. Smit EF, et al. Among authors: groen hj. Thorax. 1994 Jan;49(1):20-2. doi: 10.1136/thx.49.1.20. Thorax. 1994. PMID: 8153935 Free PMC article.

4

Phase I study of high-dose epirubicin and vinorelbine in previously untreated non-small-cell lung cancer stage IIIB-IV.

Bakker M, Groen HJ, Smit EF, Smeets J, Riggi M, Postmus PE. Bakker M, et al. Among authors: groen hj. Br J Cancer. 1995 Dec;72(6):1547-50. doi: 10.1038/bjc.1995.545. Br J Cancer. 1995. PMID: 8519675 Free PMC article. Clinical Trial.

5

Broad phase II and pharmacokinetic study of methoxy-morpholino doxorubicin (FCE 23762-MMRDX) in non-small-cell lung cancer, renal cancer and other solid tumour patients.

Bakker M, Droz JP, Hanauske AR, Verweij J, van Oosterom AT, Groen HJ, Pacciarini MA, Domenigoni L, van Weissenbruch F, Pianezzola E, de Vries EG. Bakker M, et al. Among authors: groen hj. Br J Cancer. 1998;77(1):139-46. doi: 10.1038/bjc.1998.22. Br J Cancer. 1998. PMID: 9459159 Free PMC article. Clinical Trial.

6

A phase II study of paclitaxel in heavily pretreated patients with small-cell lung cancer.

Smit EF, Fokkema E, Biesma B, Groen HJ, Snoek W, Postmus PE. Smit EF, et al. Among authors: groen hj. Br J Cancer. 1998;77(2):347-51. doi: 10.1038/bjc.1998.54. Br J Cancer. 1998. PMID: 9461009 Free PMC article. Clinical Trial.

7

Effects of gemcitabine on renal function in patients with non-small cell lung cancer.

Gietema JA, Groen HJ, Meijer S, Smit EF. Gietema JA, et al. Among authors: groen hj. Eur J Cancer. 1998 Jan;34(1):199-202. doi: 10.1016/s0959-8049(97)00354-7. Eur J Cancer. 1998. PMID: 9624259

8

Phase II study of oral platinum drug JM216 as first-line treatment in patients with small-cell lung cancer.

Fokkema E, Groen HJ, Bauer J, Uges DR, Weil C, Smith IE. Fokkema E, et al. Among authors: groen hj. J Clin Oncol. 1999 Dec;17(12):3822-7. doi: 10.1200/JCO.1999.17.12.3822. J Clin Oncol. 1999. PMID: 10577855 Clinical Trial.

9

Activity of high-dose epirubicin combined with gemcitabine in advanced non-small-cell lung cancer: a multicenter phase I and II study.

van Putten JW, Eppinga P, Erjavec Z, de Leede G, Nabers J, Smeets JB, Th Sleijfer D, Groen HJ. van Putten JW, et al. Among authors: groen hj. Br J Cancer. 2000 Feb;82(4):806-11. doi: 10.1054/bjoc.1999.1003. Br J Cancer. 2000. PMID: 10732750 Free PMC article. Clinical Trial.

10

Activity of single-agent gemcitabine as second-line treatment after previous chemotherapy or radiotherapy in advanced non-small-cell lung cancer.

van Putten JW, Baas P, Codrington H, Kwa HB, Muller M, Aaronson N, Groen HJ. van Putten JW, et al. Among authors: groen hj. Lung Cancer. 2001 Aug-Sep;33(2-3):289-98. doi: 10.1016/s0169-5002(01)00188-x. Lung Cancer. 2001. PMID: 11551424

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

452 results

Search Page